Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Perioperative management of patients taking GLP-1 receptor agonists: Multidisciplinary Consensus Statement
Rate each area to see where you stand
Nicotine Only two pre-clinical investigations on the effects of GLP-1RAs in nicotine misuse were retrieved, both showing less nicotine use and related outcomes (for example, withdrawal-induced hyperphagia) for liraglutide 108 and exendin-4 possibly related to dopamine regulation 106
The best evidence for weight and cardiometabolic benefit comes at the labeled maintenance doses or higher within clinical research, not at permanently microdoses
The MHRA and European Medicines Agency (EMA) describe it in the Summary of Product Characteristics as a dual GIP/GLP-1 receptor agonist, acknowledging its dual mechanism
Our findings support decision-making in clinical practice in patients with an indication to switch between GLP-1 RAs
US$ 20.40
US$ 23.00
US$ 27.29
US$ 24.63
US$ 28.96
US$ 22.45
